Synergistic DNA Vaccines Against COVID-19 with AI, IoT, Blockchain, and Advanced Materials

The present disclosure combines synthetic pDNA vaccines against COVID-19 with AI-based diagnostics, IoT-enabled wearables, blockchain-based tracking, and advanced biodegradable materials to create a powerful, integrated system for preventing SARS-CoV-2 infection and monitoring immune responses.

The original patent disclosed synthetic pDNA vaccines against COVID-19, but it had limitations in terms of detection, monitoring, and distribution. The present inventive concept addresses these limitations by integrating the patented DNA vaccine with distinct technologies to create a more comprehensive and effective system.

The new system comprises a DNA vaccine of claim 1, which is engineered to express a SARS-CoV receptor binding domain, and an AI-based diagnostic tool trained on a dataset of SARS-CoV-2 genomic sequences. The system further includes a blockchain-based tracking system for monitoring vaccine distribution and administration. Additionally, the system may include an IoT-enabled wearable device for monitoring the subject's immune response. The DNA vaccine can be administered orally using a composite material comprising the DNA vaccine and a biodegradable polymer.

The new claims introduce the synergistic combination of the patented DNA vaccine with AI, IoT, blockchain, and advanced materials, which is not obvious from the original patent. The integration of these distinct technologies creates a new, more powerful system that is not anticipated by the prior art.

Alternative embodiments of the inventive concept may include using different AI algorithms for diagnostic analysis, incorporating additional IoT devices for real-time monitoring, or utilizing other biodegradable materials for oral administration. Variations may also include adapting the system for other infectious diseases or integrating with existing healthcare infrastructure.

The inventive concept has significant commercial potential in the healthcare and biotechnology industries, particularly in the areas of vaccine development, disease diagnosis, and digital health. The system's integrated approach can provide a competitive advantage in the market, and its adaptability to other diseases and applications can ensure long-term growth and revenue.